A new rapid acting drug, which targets the bacterial endosymbiont Wolbachia has been discovered that could potentially cut treatment times of filariasis from… Read more »
W. David Hong received his B.Sc. degree in Chemistry from Fudan University (Shanghai, China) and Ph.D. in Synthetic Organic Chemistry at the University of Liverpool. Since then, he started work as a medicinal chemist in the areas of infectious diseases drug discovery, including antimalarials, anti-TBs and anthelmintics, and insecticide development. He is currently holding a role as the scientific team leader in an anti-Wolbachia macrofilaricidal drug discovery and development programme in the University of Liverpool.